Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Simcere Pharmaceutical

Novo Nordisk invests $100m in research in China

Expands existing site in Beijing

J&J files intravenous Simponi formulation in US

FDA approval would complement J&J’s current subcutaneously-administered product

China flag thumb

China slashes drug prices as healthcare reforms announced

Raft of measures to cut healthcare costs include 17 per cent price reduction for cancer drugs

- PMLiVE

J&J to launch ‘innovation centres’ in US, UK and China

Will target local life sciences partnerships in early-stage innovation

- PMLiVE

Pfizer’s RA drug tofacitinib tops methotrexate in phase III

Trial results back drug as major new treatment in rheumatoid arthritis

- PMLiVE

Postcards from China

Part two: The value of innovative medical education in China

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

PRA opens Beijing office to expand Chinese operations

New office adds to the CRO's existing base in Shanghai

China to be second largest online ad spender by 2014

China set to be the second largest online ad spender by 2014, with the whole of Asia-Pacific predicted to overtake Western Europe by 2013 and overall ad spend in China...

- PMLiVE

Postcards from China

Checking the pulse of the year of the dragon

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links